Nemera can help you with your licensing dossiers for ophthalmic molecules!October 9, 2017
Looking for a license for a preservative-free multidose ophthalmic product?
Medical Device and OTC
We can help you find the right ready-to-go dossier available for private labeling those molecules with Novelia®!
Thanks to its unique innovative design, Novelia® has been approved as packaging component and delivery system of multidose drug product formulated without preservatives.
User-friendly and intuitive, Novelia® contributes to improve patients’ life, allowing the delivery of safe unpreserved eye drops and improving the patients’ adherence to treatments.
Novelia® represents a major innovation in ophthalmic drug delivery by providing a preservative-free alternative for chronic treatments with the convenience of a bottle.
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera’s services and products cover several key delivery routes: Ophthalmic (multi-dose, preservative-free eyedroppers), Nasal, buccal, auricular (pumps, valves and actuators for sprays), Inhalation (pMDIs, DPIs), Dermal and transdermal (airless & atmospheric dispensers), Parenteral (auto-injectors, pens, safety devices & implanters).
Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer-owned device manufacturing.